FDA product code OIA: Neonatal Blood Collection Kit And Screening Form (Excludes Hiv Testing)

OIA is the FDA product code for neonatal blood collection kit and screening form (excludes hiv testing). It is a Class I device, regulated under 21 CFR 864.3250 and reviewed by the Clinical Chemistry panel. Devices under OIA reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it.

Definition

This product code has been established in accordance with the may 20, 1997, guidance entitled, convenience kits interim regulatory guidance, found at www.Fda.Gov/cdrh/ode/convkit.Html. This type of convenience kit, as listed in the guidance above, is under enforcement discretion, and does not require a premarket notification (510(k)) to market if it meets all criteria in the guidance.

Classification

FieldValue
Device nameNeonatal Blood Collection Kit And Screening Form (Excludes Hiv Testing)
Device classClass I
Regulation21 CFR 864.3250
Review panelCH — Clinical Chemistry
Medical specialtyPathology
Premarket route510(k) exempt

Recalls for OIA devices

FDA recall records list no recalls for product code OIA.

Frequently asked questions

What is FDA product code OIA?

OIA is the FDA product code for neonatal blood collection kit and screening form (excludes hiv testing). It is a Class I device, regulated under 21 CFR 864.3250 and reviewed by the Clinical Chemistry panel.

What device class is OIA?

Class I, regulation 21 CFR 864.3250. Typical premarket route: 510(k) exempt.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times